R.I. Nicholson

2.8k total citations
63 papers, 2.3k citations indexed

About

R.I. Nicholson is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, R.I. Nicholson has authored 63 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Genetics, 29 papers in Oncology and 17 papers in Molecular Biology. Recurrent topics in R.I. Nicholson's work include Estrogen and related hormone effects (35 papers), HER2/EGFR in Cancer Research (17 papers) and Breast Cancer Treatment Studies (9 papers). R.I. Nicholson is often cited by papers focused on Estrogen and related hormone effects (35 papers), HER2/EGFR in Cancer Research (17 papers) and Breast Cancer Treatment Studies (9 papers). R.I. Nicholson collaborates with scholars based in United Kingdom, United States and Germany. R.I. Nicholson's co-authors include Julia M.W. Gee, Ian O. Ellis, J.F.R. Robertson, R.W. Blamey, A. E. Wakeling, David L. Manning, Denise Barrow, Iain R. Hutcheson, R A McClelland and Sarah E. Pinder and has published in prestigious journals such as The Lancet, Advanced Materials and Journal of Clinical Oncology.

In The Last Decade

R.I. Nicholson

63 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R.I. Nicholson United Kingdom	25	1.1k	1.0k	884	582	283	63	2.3k
R A McClelland United Kingdom	30	1.3k 1.2×	1.1k 1.0×	982 1.1×	505 0.9×	244 0.9×	45	2.5k
David L. Manning United Kingdom	15	1.0k 0.9×	739 0.7×	831 0.9×	316 0.5×	222 0.8×	25	1.7k
Janice M. Knowlden United Kingdom	23	1.2k 1.1×	810 0.8×	1.1k 1.3×	428 0.7×	318 1.1×	37	2.1k
Diane Bronzert United States	23	834 0.8×	897 0.9×	1.0k 1.1×	327 0.6×	99 0.3×	29	2.1k
Vera Cappelletti Italy	27	1.1k 1.1×	523 0.5×	1.0k 1.2×	1.0k 1.8×	391 1.4×	108	2.4k
Michael Dukes United Kingdom	11	902 0.8×	981 1.0×	1.1k 1.2×	449 0.8×	514 1.8×	14	2.5k
E. Berns Netherlands	23	921 0.9×	488 0.5×	1.0k 1.2×	763 1.3×	168 0.6×	42	2.0k
Jiang Shou United States	15	1.3k 1.2×	947 0.9×	1.4k 1.6×	524 0.9×	352 1.2×	20	2.4k
Hisashi Hirakawa Japan	24	839 0.8×	741 0.7×	805 0.9×	752 1.3×	286 1.0×	63	2.0k
Ignasi Tusquets Spain	23	970 0.9×	448 0.4×	608 0.7×	627 1.1×	219 0.8×	73	1.9k

Countries citing papers authored by R.I. Nicholson

Since Specialization

Citations

This map shows the geographic impact of R.I. Nicholson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.I. Nicholson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.I. Nicholson more than expected).

Fields of papers citing papers by R.I. Nicholson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.I. Nicholson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.I. Nicholson. The network helps show where R.I. Nicholson may publish in the future.

Co-authorship network of co-authors of R.I. Nicholson

This figure shows the co-authorship network connecting the top 25 collaborators of R.I. Nicholson. A scholar is included among the top collaborators of R.I. Nicholson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.I. Nicholson. R.I. Nicholson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Menezes, Ana Catarina, Rachel Jones, R.I. Nicholson, et al.. (2022). Increased expression of RUNX3 inhibits normal human myeloid development. Leukemia. 36(7). 1769–1780. 10 indexed citations

Nicholson, R.I., Ana Catarina Menezes, Claire Seedhouse, et al.. (2022). Protein Kinase C Epsilon Overexpression Is Associated With Poor Patient Outcomes in AML and Promotes Daunorubicin Resistance Through p-Glycoprotein-Mediated Drug Efflux. Frontiers in Oncology. 12. 840046–840046. 8 indexed citations

McCloy, Rachael A., Caroline G. P. Roberts, Ebru Boslem, et al.. (2013). Role of endoplasmic reticulum stress induction by the plant toxin, persin, in overcoming resistance to the apoptotic effects of tamoxifen in human breast cancer cells. British Journal of Cancer. 109(12). 3034–3041. 15 indexed citations

Hiscox, Stephen, Nicola Jordan, Christopher G. Smith, et al.. (2008). Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells. Breast Cancer Research and Treatment. 115(1). 57–67. 59 indexed citations

Jones, Helen, et al.. (2006). Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells. British Journal of Cancer. 95(2). 172–180. 39 indexed citations

Robertson, J.F.R., Semiglazov Vf, Gia Nemsadze, et al.. (2006). Effects of fulvestrant 250mg in premenopausal women with oestrogen receptor-positive primary breast cancer. European Journal of Cancer. 43(1). 64–70. 26 indexed citations

Nicholson, R.I., Iain R. Hutcheson, D. Britton, et al.. (2005). Growth factor signalling networks in breast cancer and resistance to endocrine agents: new therapeutic strategies. The Journal of Steroid Biochemistry and Molecular Biology. 93(2-5). 257–262. 47 indexed citations

Jones, Helen E., Julia M.W. Gee, KM Taylor, et al.. (2005). Development of strategies for the use of anti-growth factor treatments. Endocrine Related Cancer. 12(Supplement_1). S173–S182. 31 indexed citations

Nicholson, R.I., et al.. (2004). Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: new opportunities for therapy. Endocrine Related Cancer. 11(4). 623–641. 74 indexed citations

10.

Purohit, A., L. W. Lawrence Woo, Denise Barrow, et al.. (2001). Non-steroidal and steroidal sulfamates: new drugs for cancer therapy. Molecular and Cellular Endocrinology. 171(1-2). 129–135. 43 indexed citations

11.

Nicholson, R.I., Iain R. Hutcheson, M. E. Harper, et al.. (2001). Modulation of epidermal growth factor receptor in endocrine-resistant, oestrogen receptor-positive breast cancer.. Endocrine Related Cancer. 8(3). 175–182. 131 indexed citations

12.

Howell, Anthony, Elizabeth Anderson, R.W. Blamey, et al.. (1998). The Primary Use of Endocrine Therapies. Recent results in cancer research. 152. 227–244. 21 indexed citations

13.

Osborne, C. Kent, et al.. (1995). Comparison of the Effects of a Pure Steroidal antiestrogen With Those of Tamoxifen in a Model of Human Breast Cancer. JNCI Journal of the National Cancer Institute. 87(10). 746–750. 297 indexed citations

14.

Manning, David L., John F. R. Robertson, Ian O. Ellis, et al.. (1994). Oestrogen-regulated genes in breast cancer: Association of pLIV1 with lymph node involvement. European Journal of Cancer. 30(5). 675–678. 84 indexed citations

15.

Schmid, Kurt Werner, Ian O. Ellis, Julia M.W. Gee, et al.. (1993). Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 422(2). 153–159. 97 indexed citations

16.

Locker, A P, Ian O. Ellis, C.W. Elston, et al.. (1991). An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast.. PubMed. 17(3). 251–7. 89 indexed citations

17.

McClelland, R A, et al.. (1991). A multicentre study into the reliability of steroid receptor immunocytochemical assay quantification. European Journal of Cancer and Clinical Oncology. 27(6). 711–715. 54 indexed citations

18.

Robertson, J.F.R., R.I. Nicholson, K.J. Walker, & R.W. Blarney. (1989). Zoladex in Advanced Breast Cancer. Hormone Research. 32(1). 206–208. 5 indexed citations

19.

Chester, J F, R.I. Nicholson, J V Lever, A R Turnbull, & D C Britton. (1989). Oophorectomy has no effect on experimental pancreatic carcinogenesis in the Syrian hamster. British Journal of Cancer. 59(5). 696–697. 3 indexed citations

20.

Nicholson, R.I., Kirsten Gotting, Julia M.W. Gee, & Kate Walker. (1988). Actions of oestrogens and antioestrogens on rat mammary gland development: Relevance to breast cancer prevention. Journal of Steroid Biochemistry. 30(1-6). 95–103. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact